Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks

被引：8

作者：

Konstantinidis, Lazaros ^{[1
]}

Zografos, Leonidas ^{[1
]}

机构：

[1] Univ Lausanne, Jules Gonin Eye Hosp, CH-1015 Lausanne, Switzerland

来源：

ACTA OPHTHALMOLOGICA | 2010年 / 88卷 / 03期

关键词：

CHOROIDAL NEOVASCULARIZATION; BEVACIZUMAB AVASTIN; SECONDARY;

D O I：

10.1111/j.1755-3768.2009.01754.x

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：e100 / e101

页数：2

共 5 条

[1] Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks [J].

Apte, R. S. .

EYE, 2008, 22 (05) :734-735

[2] Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum [J].

Bhatnagar, Pawan ;

Freund, K. Bailey ;

Spaide, Richard F. ;

Klancnik, James M., Jr. ;

Cooney, Michael J. ;

Ho, Ivan ;

Fine, Howard F. ;

Yannuzzi, Lawrence A. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07) :897-902

[3]

Derriman L, 2008, RETINA-J RET VIT DIS, V28, P910, DOI 10.1097/IAE.0b013e31816d81d0

[4] Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin) [J].

Neri, P. ;

Salvolini, S. ;

Mariotti, C. ;

Mercanti, L. ;

Celani, S. ;

Giovannini, A. .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) :155-158

[5] Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks [J].

Wiegand, T. W. ;

Rogers, A. H. ;

McCabe, F. ;

Reichel, E. ;

Duker, J. S. .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (01) :47-51

← 1 →